Xi An Zhan Sen produces and sells more than 20 patented drugs, involving mycology, gastroenterology, psychiatry, neurology, anesthesia and analgesia, allergy, anti-infection and other fields.
Xi 'an Jensen Company is headquartered in Beijing Central Business District, with its factory in Xi 'an and more than 20 offices all over the country. At present, Xi 'an Zhan Sen has 65,438+0,500 outstanding employees.
Xi 'an Janssen Factory is located in Xi 'an, an ancient city, covering an area of 65,438 0.70 mu and a building area of 35,620 square meters. Its production and management have reached the requirements of the World Health Organization (WHO) and the standards of good manufacturing practice (GMP) in China and the European Union, and adopted the internationally accepted modern enterprise management system for operation and management.
Xi anjangsang pharmaceutical co., ltd has the most advanced production facilities and testing equipment. From raw materials entering the factory, manufacturing, packaging to finished product inspection, all links are strictly supervised and controlled to ensure the quality of drugs.
During the period of 1997, Xi Anyangshen took the lead in passing the national drug GMP certification among domestic pharmaceutical enterprises. Since 1994, Xi Anyansen has started to implement SOQ (symbol of quality) activities, continuously improving product quality and process management, and continuously providing quality services to customers, so as to keep the company's best competitiveness. 1998, Xi An Zhan Sen won the bronze medal of SOQ of Johnson & Johnson Group. 1999, obtained the national ISO9002 quality management system certification. In 2000, Xi 'an Zhan Sen invested nearly10 million dollars to transform the production environment of the factory, which made Xi 'an Zhan Sen's comprehensive indicators in production environment and product quality reach the international advanced level. In the same year, it passed the national OHSMS/OHSAS 1800 1 occupational safety and health management system certification.
On June 5438+ 10, 2004, Xi Anyansen successfully passed the examination of EU GMP Audit Office, and obtained the certification of solid production and non-solid production at the same time. It indicates that our factory building, equipment, environment, personnel, file system and quality management system fully meet the European GMP standards, and the products produced under this system can fully meet the requirements of the European market for drug quality.
Yang Sen of Xi 'an regards environmental protection as his sacred duty, and minimizes the adverse impact on the environment, prevents environmental pollution and makes rational use of resources in all products, processes, technologies and equipment. 1998, Xi' an Zhan Sen obtained the ISO 1400 1 environmental management system certification issued by China Quality Certification Committee, becoming the first enterprise of Johnson & Johnson Group in the Asia-Pacific region. As a subsidiary of Johnson & Johnson Group, Xi 'an Zhan Sen carried out its "Global Environmental Policy" and won the honorary awards from 65438 to 0999 in the global environmental performance assessment of Johnson & Johnson Group. In 200 1 year, Xi An Jensen won the honorary award of global environmental performance leadership evaluation of Johnson & Johnson Group Company again for his outstanding performance in environmental protection.
Won the first "Bright Public Welfare Award" in 2004.
In 2004, it was rated as "the most cultural value brand in China"
In 2004, it was selected as "Top Ten Outstanding Contribution Industrial Enterprises" in Xi.
In 2003, it won the title of "National Advanced Unit for After-sales Service of Famous Products"
In 2002, it was selected as "the most admired foreign-funded company in China" and "the top ten most socially responsible foreign-funded enterprises in China" by Fortune magazine (Chinese version).
In 2002, he was selected as "the best employer in the eyes of human resource managers" by Fortune magazine (Chinese version), and Xi Anyansen was the only pharmaceutical company selected.
& gt& gt top
On 200 1, China Red Cross awarded Xi An Jansen the medal of "Humanitarian Service" in recognition of Xi An Jansen's contribution in promoting the expansion of "China Hematopoietic Stem Cell Donor Database".
200 1, Xi' an Zhan Sen won the "Practice Award" in the "China Corporate Culture Innovation Selection" sponsored by China Corporate Culture Research Association.
In 20001year, Xi' an Zhan Sen won the Johnson & Johnson global environmental performance leadership assessment honor award again for its outstanding performance in environmental protection.
In 2000, he was awarded "Outstanding Contribution Award" by happiness project Organizing Committee.
In 2000, it passed the national OHSMS/OHSAS 1800 1 occupational safety and health management system certification.
In 2000, Ralph Larsen, former chairman and CEO of Johnson & Johnson Company of the United States, won the "Kyle Poirot" China Award for his contribution from the State Administration of Foreign Experts Affairs of China and the American Volunteer Donation Association.
1999 was rated as one of the "Top Ten Most Admired Foreign Enterprises" in China by Fortune (Chinese Version), including:
The top ten most admired companies
Top ten companies whose products and services are most appreciated.
Top ten companies that can best show good social morality.
Top Ten Most Reliable Partners or Suppliers
1999, obtained the national ISO9002 quality system certification.
1999, won the honorary award in the Johnson & Johnson Global environmental performance evaluation.
& gt& gt top
1998, and obtained the ISO 1400 1 environmental management system certification certificate issued by the Environmental Management System Audit Center of the State Environmental Protection Bureau.
1998, won the global SOQ bronze award of "quality symbol" of Johnson & Johnson Group.
1997, obtained GMP certification No.007 issued by China Drug Certification Committee.
1997, the sales revenue of chemical preparation manufacturing industry in China ranks first.
1996, ranking first among the top 50 pharmaceutical industries in China.
1995, the first national top ten foreign-funded pharmaceutical enterprises ranked first.
1994, the eighth national top ten joint ventures ranked second.
From 65438 to 0994, the pharmaceutical manufacturing industry ranked second among the 500 industrial enterprises with the best economic benefits in China.
1994, the largest pharmaceutical manufacturing enterprise in China ranks ninth.
1994, an outstanding enterprise in the national pharmaceutical industry.
& gt& gt top
1993, the seventh national top ten joint ventures ranked first.
1993 was awarded the first place in the "Top Ten" enterprises of industrial pollution prevention and control in Shaanxi Province by the State Environmental Protection Bureau.
1993, national advanced environmental protection unit.
1993, the best credit customer for foreign-invested enterprise loans.
1992, the top ten enterprises in the pharmaceutical industry ranked first.
1992, the sixth national top ten joint ventures ranked first.
1992, the top ten foreign-funded enterprises with high per capita profits and taxes in China ranked fourth.
1992, one of the national 100 advanced environmental protection units.
199 1 year ranked fourth among the top ten joint ventures in China.
199 1 year, China pharmaceutical industry ranks first among the 50 enterprises with the best economic benefits.
199 1 year, ranking sixth among the top 50 enterprises in China pharmaceutical industry.
199 1 year, ranking first among the 500 best economic and industrial enterprises in China.
1990, national advanced enterprise in drug packaging management.
Eight Factors of Xi An Yangsen's Success (Shaanxi Daily, 2005+00.24)
Xi An Yang Sen is one of the earliest joint ventures in China, and also the pioneer of western development. After 20 years' development, Xi 'an Janssen has become a leading enterprise in China's pharmaceutical industry and a model of western development and opening up.
The development course and achievements of Xi An Jansen have aroused widespread concern from all walks of life, and everyone is asking about the factors of Xi An Jansen's success. We are constantly analyzing and summarizing ourselves, carrying forward the past into the future, realizing scientific development and making continuous contributions to the development of the western region. We summarized eight factors of Xi 'an Zhan Sen's success, including external factors and internal factors. In a word, only by persisting in reform and opening up can development prosper.
First, seize the opportunity of reform and opening up. The leading bodies of the provincial party committee, the provincial government, the Xi Municipal Party Committee and the municipal government have unswervingly implemented the policy of reform and opening up, and provided guarantees for the development of foreign-funded enterprises with a bold and pragmatic style, creating a good environment and conditions.
During the 20-year development of Yang Sen in Xi 'an, he has been cared for by provincial and municipal leaders. They visited the company many times and gave timely instructions and solutions to the problems and difficulties we reflected. This is not the preference of the leaders for Yang Sen of Xi 'an, but the determination and sincerity of the provincial and municipal governments to attract investment.
Second, Shaanxi has outstanding achievements and rich advantages in energy and talents.
Shaanxi is a big province of science and education, with profound historical and cultural accumulation and superior humanistic and scientific environment. Yang Sen of Xi attracts outstanding talents here every year. Xi' an is our talent base. Through the training of Xi' an Jensen, a large number of outstanding talents have been delivered to the pharmaceutical industry.
Shaanxi province is rich in energy reserves. Qinchuan, 800 Li, the weather is good. Starting a business here, we feel the advantages of good weather, geographical location and human harmony, and we have never been troubled by energy supply.
Third, the shareholders of the joint venture cooperate sincerely. Janssen of Belgium and four shareholders in China agree that Xi 'an Janssen is a long-term cooperation project between China and Belgium, and all of them invest and contribute in the same place to establish a joint venture pharmaceutical company with international standards, regardless of short-term gains and losses.
Fourthly, Xi 'an Zhan Sen has high-quality products suitable for China's national conditions and clinical needs.
Xi An Zhan Sen has been committed to selectively introducing high-quality patented products from Belgian Zhan Sen Company and American Johnson & Johnson Company into China, benefiting patients in China, bringing the latest information of medical development to medical workers in China, and providing scientific basis and guidance for doctors and patients to use drugs scientifically. High-quality products and scientific promotion mode have won the dependence of doctors and patients and the affirmation of colleagues in the industry.
Fifth, Xi 'an Zhan Sen has world-class production facilities. In the negotiation of 1983 Sino-Belgian joint venture, China took the introduction of advanced management technology in the pharmaceutical industry of developed countries as the primary condition in the agreement, and the production workshop was designed and built in strict accordance with the GMP standards of Jensen Company of Belgium at that time. This enabled Xi 'an Zhan Sen to be established at a high starting point and level from the very beginning. 1997, Xi Anyangsen took the lead in passing the national GMP certification in China. In 2000, Yang Sen Investment of Xi 'an started the GMP continuous transformation plan. This year's transformation plan has basically reached the GMP level in Europe and America. From June 5, 2004 to 10, Xi Anyansen successfully passed the GMP certification of the European Union.
Sixthly, Xi An Jansen has a strong corporate culture that integrates the essence of Chinese and Western cultures, that is, "honesty is the foundation and perfection is the end". The corporate culture of Xi 'an Zhan Sen combines the essence of Chinese and Western cultures, which is easily accepted by China employees, thus forming a great cohesion and becoming the cornerstone of Xi 'an Zhan Sen's success.
Seventh, Yang Sen has a strong talent advantage in Xi. Xi An Zhan Sen has gathered a group of outstanding employees who share common values. Among them, there are both local elites and international talents. They are both professional and dedicated. This multicultural team has strong leadership and creativity. The personal dedication of managers at all levels is particularly commendable.
Eighth, sincerely repay the society. Yang Sen of Xi 'an has been committed to the health of the people in China for a long time. Therefore, giving back to the society is the concept practiced by Xi An Jansen. Yang Sen's twenty years of development in Xi is also twenty years of continuous contribution to society. Xi An Yangsen's total investment in supporting the development of health education and charity in China amounts to several hundred million yuan. Huge public welfare investment has won the respect and praise of the society.
Looking back on the past, we have achieved fruitful results and look forward to the future. We are full of confidence. At present, Xi Jansen is implementing two development strategies.
First of all, "products guide the future" is the future development strategy of Xi An Jansen. From 2004 to 20 14, during 10, Xi 'an Zhan Sen plans to introduce and market more than 20 high-tech new products, involving cardiovascular and cerebrovascular diseases, cancer, pain management, central nervous system, men's health and women's health. According to Yang Sen's plan, the sales of new products will account for 29% of the total sales. New products and new fields are the driving force for Xi 'an Janssen's development, and also the key for Xi 'an Janssen to win the market in the future!
Second, establish a first-class pharmaceutical production base in the Asia-Pacific region and even the world. Xi Anyansen will continue to invest in improving the GMP level of Xi Anyansen, and accelerate the FDA certification of the United States on the basis of passing the EU GMP certification, so that Xi Anyansen's products will become synonymous with "high quality" and sell well all over the world.
At present, Xi Yangsen is entering a new period of rapid development. In order to implement Scientific Outlook on Development, Xi An Yang Sen has formulated a new mission and vision, that is, under the guidance of the "creed", by providing innovative and international-level drugs, we will sincerely cooperate with people from all walks of life in China to promote the lofty cause of saving human lives and improving the quality of life; As always, it has maintained its leading position in the pharmaceutical industry in China. All employees of Xi 'an Zhan Sen are working hard for this mission and vision. Xi 'an Zhan Sen firmly believes that in the next twenty years, he can continue to write more brilliant chapters.
(The writer is the deputy general manager of Shaanxi Pharmaceutical Corporation and the chairman of xi Anrang Sang Company. )